NEWS
![[Medipana] C&R Research Achieves A New Performance Record In The Third Quarter… Continued Operating Profit Surplus](http://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[Medipana] C&R Research achieves a new performance record in the third quarter… Continued operating profit surplus
2023-11-14
C&R Research, a contract research organization (CRO), has achieved a new performance record in the third quarter and continues to…
[Hankyung] C&R Research, ‘Highest score ever’ in Korea National Enterprise for Clinical Trials (KoNECT) evaluation report
2023-11-07
C&R Research, a domestic contract research organization (CRO), received the highest score ever, breaking existing records in major items of…
[Etoday] C&R Research “Neurobiogen obesity treatment, U.S. FDA Pre-IND application”
2023-09-25
C&R Research announced on the 25th that it has decided to submit a Phase 2 Pre-IND (pre-meeting) application to the…
[Etoday] C&R Research conducts global clinical trials for Shaperon atopic dermatitis treatment ‘NuGel’
2023-09-18
C&R Research announced on the 18th that it has decided to conduct a global clinical trial with Shaperon and InHandPlus.…
[Newsprime] C&R Research Strengthens Dementia Disease Clinical Trial Services
2023-09-13
[Newsprime] C&R Research (359090), Korea's first commissioned clinical trial (CRO) company, conducted strategic work for joint academic research and technological…